Hydralazine Hcl
Rank #278 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$43.2M
Total Cost
2,256,779
Total Claims
$43.2M
Total Cost
54,726
Prescribers
$19
Cost per Claim
479,677
Beneficiaries
4,380,597
30-Day Fills
$790
Avg Cost/Provider
41
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$43.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $43.2M total
🔎 Data Overview
At $19.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Hydralazine Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Terence Frinks | Family Practice | Tucker, GA | 1,719 | $29K |
| 2 | Rajesh Agarwal | Internal Medicine | Mayfield Heights, OH | 1,101 | $26K |
| 3 | Michael Satchell | Family Practice | Albany, GA | 2,713 | $25K |
| 4 | Gary Reznik | Cardiology | Los Angeles, CA | 1,832 | $24K |
| 5 | Mikhail Chilingaryan | General Practice | Pittsburgh, PA | 1,450 | $22K |
| 6 | Edward Carlos | Internal Medicine | Mobile, AL | 659 | $20K |
| 7 | Ashar Luqman | Nephrology | Sioux City, IA | 1,560 | $20K |
| 8 | Timothy Estes | Family Practice | Jackson, MS | 1,490 | $20K |
| 9 | Tao Duong | Cardiology | Westminster, CA | 632 | $19K |
| 10 | Donald Vollmer | Family Practice | Hendersonville, TN | 1,712 | $19K |
| 11 | Dana Nash | Family Practice | Memphis, TN | 1,813 | $18K |
| 12 | Patrick O'brien | Physical Medicine and Rehabilitation | Raleigh, NC | 1,102 | $18K |
| 13 | Vivek Gupta | Internal Medicine | Chicago, IL | 852 | $18K |
| 14 | Farooq Ahmed | Family Practice | Skokie, IL | 1,060 | $17K |
| 15 | Shahid Khan | Cardiology | Memphis, TN | 563 | $16K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 275 | Baclofen (Baclofen) | $44.2M | 1,916,226 |
| 276 | Fluoxetine Hcl (Fluoxetine Hcl) | $43.9M | 2,891,768 |
| 277 | Patiromer Calcium Sorbitex (Veltassa) | $43.4M | 40,534 |
| 278 | Hydralazine Hcl (Hydralazine Hcl) | $43.2M | 2,256,779 |
| 279 | Leuprolide Acetate (Lupron Depot) | $42.7M | 9,949 |
| 280 | Efgartigimod Alfa-Fcab (Vyvgart) | $42.6M | 1,005 |
| 281 | Hydrochlorothiazide (Hydrochlorothiazide) | $42.4M | 7,879,021 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology